Pharmacogenomics Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Therapeutic, By Technology, By Country, & By Region

  • Report Id: HCDHR 2417
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Pharmacogenomics Market Report Overview

Pharmacogenomics market garnered a revenue of USD 7.21 billion in the year 2019 globally and is anticipated to reach USD 27.19 billion by 2027. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Pharmacogenomics market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Pharmacogenomics Total Available Market (TAM) Size
  • Pharmacogenomics Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Pharmacogenomics Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Model
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Pharmacogenomics Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Pharmacogenomics Market: Therapeutic Insights
4.1. Global Therapeutic Historic Market Data & Future Forecasts, 2016-2027
4.1.1. Historic Market Data & Future Forecasts, 2016-2027
4.1.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.1.3. Oncology
4.1.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.1.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.1.4. Neurological Disorders
4.1.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.1.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.1.5. Cardiovascular Disorders
4.1.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.1.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.1.6. Immunological Disorders
4.1.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.1.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.1.7. Others
4.1.7.1. Historic Market Data & Future Forecasts, 2016-2027
4.1.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027

Chapter 5. Pharmacogenomics Market: Technology Insights
5.1. Global Technology Historic Market Data & Future Forecasts, 2016-2027
5.1.1. Historic Market Data & Future Forecasts, 2016-2027
5.1.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.1.3. PCR
5.1.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.1.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.1.4. In-situ Hybridization
5.1.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.1.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.1.5. Immunohistochemistry
5.1.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.1.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.1.6. Sequencing
5.1.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.1.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.1.7. Others
5.1.7.1. Historic Market Data & Future Forecasts, 2016-2027
5.1.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Pharmacogenomics Market: Regional Insights
6.1. Global Pharmacogenomics Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.6.3. UAE
6.6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.3.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.6.3.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
6.6.4. South Africa
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Therapeutic, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Technology, 2016-2027
Chapter 7. Company Profiles
7.1. Astra Zeneca
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Oxford Cancer Biomarkers Ltd.
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Merck & Co Inc
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Leica Biosystems Nussloch GmBH
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Foundation Medicine, Inc
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Agilent Technologies
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Myriad Genetics Inc.
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. Qiagen NV
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. F Hoffman La Roche
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. Illumina Inc.
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives

List of Tables
Table 1 Pharmacogenomics Market Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Pharmacogenomics Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 5 Oncology Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 Neurological Disorders Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 Cardiovascular Disorders Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 Immunological Disorders Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Others Disorders Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Technology Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 PCR Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 In-situ Hybridization Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Immunohistochemistry Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 Sequencing Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 16 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 North America Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 North America Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 19 North America Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 20 U.S. Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 U.S. Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 22 U.S. Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 23 Canada Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 24 Canada Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 25 Canada Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 26 Europe Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 27 Europe Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 28 Europe Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 29 U.K. Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 30 U.K. Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USBillion)
Table 31 U.K. Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 32 Germany Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 33 Germany Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 34 Germany Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 35 France Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 36 France Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 37 France Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 38 Asia Pacific Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 39 Asia Pacific Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 40 Asia Pacific Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 41 China Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 42 China Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 43 China Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 44 India Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 45 India Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 46 India Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)

Table 47 Japan Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 48 Japan Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 49 Japan Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 50 South Korea Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 51 South Korea Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 52 South Korea Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 53 Latin America Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 54 Latin America Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 55 Latin America Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 56 Brazil Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 57 Brazil Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 58 Brazil Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 59 Mexico Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 60 Mexico Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 61 Mexico Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 62 Middle East & Africa Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 63 Middle East & Africa Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 64 Middle East & Africa Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 65 UAE Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 66 UAE Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 67 UAE Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
Table 68 South Africa Pharmacogenomics Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 69 South Africa Pharmacogenomics Market Data & Future Forecasts, By Therapeutic, 2016-2027 (USD Billion)
Table 70 South Africa Pharmacogenomics Market Data & Future Forecasts, By Technology, 2016-2027 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Pharmacogenomics Market, by 2016-2027 (USD Billion)
Fig.3 Pharmacogenomics Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Pharmacogenomics Market Driver Anlaysis
Fig.6 Pharmacogenomics Market Restraint Analysis
Fig.7 Pharmacogenomics Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Pharmacogenomics Market
Fig.10 Company Market Share Analysis, 2019

Pharmacogenomics Market Segmentation:

Pharmacogenomics Market, By Therapeutic (2016-2017)

  • Oncology
  • Neurological Disorders
  • Cardiovascular Disorders
  • Immunological Disorders
  • Others

Pharmacogenomics Market, By Technology (2016-2017)

  • PCR
  • In-situ Hybridization
  • Immunohistochemistry
  • Sequencing
  • Others

Pharmacogenomics Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Pharmacogenomics Market:

  • Astra Zeneca
  • Oxford Cancer Biomarkers Ltd.
  • Merck & Co Inc
  • Leica Biosystems Nussloch GmBH
  • Foundation Medicine, Inc
  • Agilent Technologies
  • Myriad Genetics Inc.
  • Qiagen NV
  • F Hoffman La Roche
  • Illumina Inc.

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.